{"matchedTerms": [], "ambiguousTerms": [{"searchTerm": "272", "geneName": "AMPD3", "geneLongName": "ADENOSINE MONOPHOSPHATE DEAMINASE 3", "entrezId": 272, "geneCategories": [{"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}, {"id": "4866b8ad-3c3e-4c04-802f-587f697212db", "name": "ENZYME"}], "interactions": []}, {"searchTerm": "272", "geneName": "PARP2", "geneLongName": "POLY(ADP-RIBOSE) POLYMERASE 2", "entrezId": 10038, "geneCategories": [{"id": "8ec3ee55b5ac4e3f8a263748945a5ce4", "name": "DNA REPAIR"}, {"id": "7091f8a01cac4ec8b5f5b150cdacfb46", "name": "HISTONE MODIFICATION"}, {"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}, {"id": "0d157beb-fd17-404d-8755-3a81aa5ed704", "name": "CLINICALLY ACTIONABLE"}], "interactions": [{"interactionId": "5b9ad729-589a-4716-a590-bb5f7ab9b0ce", "interactionTypes": ["antagonist", "inhibitor"], "drugName": "RUCAPARIB", "drugConceptId": "chembl:CHEMBL1173055", "sources": ["MyCancerGenome", "ClearityFoundationClinicalTrial", "ChemblInteractions", "PharmGKB"], "pmids": [], "score": 1.07}, {"interactionId": "7fd0d81f-74c6-4b94-a464-a5f3256dd76a", "interactionTypes": ["inhibitor"], "drugName": "RUCAPARIB CAMSYLATE", "drugConceptId": "chembl:CHEMBL3833368", "sources": ["ChemblInteractions"], "pmids": [], "score": 2.94}, {"interactionId": "ad883424-cf69-4af7-879c-baf5b0c0b876", "interactionTypes": ["inhibitor"], "drugName": "TALAZOPARIB TOSYLATE", "drugConceptId": "chembl:CHEMBL3137318", "sources": ["ChemblInteractions"], "pmids": [], "score": 4.42}, {"interactionId": "f6fc55e8-0255-4fa4-9f29-bf8c16cf8a3c", "interactionTypes": ["antagonist", "inhibitor"], "drugName": "NIRAPARIB", "drugConceptId": "chembl:CHEMBL1094636", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 4.91}, {"interactionId": "f78ae52f-e8ef-409e-83d3-e78e7a64eb86", "interactionTypes": ["inhibitor"], "drugName": "OLAPARIB", "drugConceptId": "chembl:CHEMBL521686", "sources": ["MyCancerGenome", "ClearityFoundationClinicalTrial", "ChemblInteractions"], "pmids": [25981132], "score": 1.31}, {"interactionId": "9cb330d1-e13e-45f2-9cb9-cf9244c14d77", "interactionTypes": ["inhibitor"], "drugName": "TALAZOPARIB", "drugConceptId": "chembl:CHEMBL3137320", "sources": ["ChemblInteractions"], "pmids": [26652717], "score": 1.61}, {"interactionId": "52c1293a-0665-4f43-ae63-7328154e0719", "interactionTypes": ["inhibitor"], "drugName": "VELIPARIB", "drugConceptId": "chembl:CHEMBL506871", "sources": ["TALC", "MyCancerGenome", "ClearityFoundationClinicalTrial", "ChemblInteractions", "CancerCommons", "MyCancerGenomeClinicalTrial"], "pmids": [10592235], "score": 6.18}]}], "unmatchedTerms": []}